DK0712311T3 - Antiglucocorticoidsteroider til behandling af angstlidelser - Google Patents

Antiglucocorticoidsteroider til behandling af angstlidelser

Info

Publication number
DK0712311T3
DK0712311T3 DK94924819T DK94924819T DK0712311T3 DK 0712311 T3 DK0712311 T3 DK 0712311T3 DK 94924819 T DK94924819 T DK 94924819T DK 94924819 T DK94924819 T DK 94924819T DK 0712311 T3 DK0712311 T3 DK 0712311T3
Authority
DK
Denmark
Prior art keywords
treatment
pct
anxiety disorders
antiglucocorticoid steroids
antiglucocorticoid
Prior art date
Application number
DK94924819T
Other languages
English (en)
Inventor
Bernardus Wynand Machi Peeters
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Application granted granted Critical
Publication of DK0712311T3 publication Critical patent/DK0712311T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK94924819T 1993-08-04 1994-07-28 Antiglucocorticoidsteroider til behandling af angstlidelser DK0712311T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP93202304 1993-08-04
PCT/EP1994/002513 WO1995004536A1 (en) 1993-08-04 1994-07-28 Antiglucocorticoid steroids for the treatment of anxiety disorders

Publications (1)

Publication Number Publication Date
DK0712311T3 true DK0712311T3 (da) 1999-06-21

Family

ID=8214027

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94924819T DK0712311T3 (da) 1993-08-04 1994-07-28 Antiglucocorticoidsteroider til behandling af angstlidelser

Country Status (11)

Country Link
US (1) US5741787A (da)
EP (1) EP0712311B1 (da)
JP (1) JP3828926B2 (da)
AT (1) ATE171873T1 (da)
AU (1) AU687088B2 (da)
CA (1) CA2166332C (da)
DE (1) DE69413829T2 (da)
DK (1) DK0712311T3 (da)
ES (1) ES2124905T3 (da)
NZ (1) NZ271363A (da)
WO (1) WO1995004536A1 (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2149496C (en) * 1994-05-19 2006-12-19 Ronald Gebhard 11,21-bisphenyl-19-norpregnane derivatives
IL118974A (en) * 1995-08-17 2001-09-13 Akzo Nobel Nv History 11 - (Transformed Phenyl) - Astra - 4, 9 - Diane, their preparation and pharmaceutical preparations containing them
IL119649A (en) * 1995-11-30 2002-03-10 Akzo Nobel Nv Preparation of Cyclic Kills of History - 3 keto- (5) 10, (-9) 11 steroidadians
DK0780397T3 (da) * 1995-12-22 1999-03-29 Jenapharm Gmbh 17alfa-cyanomethylestra-4,9-dien-derivater, fremgangsmåde til deres fremstilling og farmaceutiske præparater indeholdende d
US6900193B1 (en) * 1996-05-01 2005-05-31 The United States Of America As Represented By The Department Of Health And Human Services Structural modification of 19-norprogesterone I: 17-α-substituted-11-β-substituted-4-aryl and 21-substituted 19-norpregnadienedione as new antiprogestational agents
CA2253673C (en) * 1996-05-01 2009-09-08 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services 21-substituted progesterone derivatives as new antiprogestational agents
FR2757400B1 (fr) * 1996-12-19 1999-12-17 Hoechst Marion Roussel Inc Application des composes antiglucocorticoides dans le traitement des psychoses ou des comportements addictifs
WO1999061055A1 (en) 1998-05-22 1999-12-02 The Board Of Trustees Of The Leland Stanford Junior University Bifunctional molecules and therapies based thereon
CA2338968C (en) * 1998-07-30 2010-04-27 Michael J. Coghlan Glucocorticoid-selective agents
JP4202250B2 (ja) 2001-07-25 2008-12-24 バイオマリン ファーマシューティカル インコーポレイテッド 血液脳関門輸送を調節するための組成物および方法
US7250408B2 (en) 2002-12-16 2007-07-31 Bayer Schering Pharma Ag Glucocorticoid receptor antagonists for prophylaxis and therapy of glucocorticoid-mediated hypogonadism, of sexual dysfunction and/or infertility
CA2516319C (en) * 2003-02-28 2012-09-18 The Government Of The United States Of America, As Represented By The Se Cretary, Department Of Health And Human Services Method for preparing 17.alpha.-acetoxy-11.beta.-(4-n,n-dimethylaminophenyl)-19-norpregna-4,9-diene-3,20-dione, intermediates thereof, and methods for the preparation of such intermediates
US8097606B2 (en) * 2003-07-23 2012-01-17 Corcept Therapeutics, Inc. Antiglucocorticoids for the treatment of catatonia
DK1889198T3 (da) 2005-04-28 2015-02-09 Proteus Digital Health Inc Farma-informatiksystem
JP2009508494A (ja) 2005-09-16 2009-03-05 ラプトール ファーマシューティカル インコーポレイテッド Ｃｒを含むタンパク質に対して特異的な受容体−結合タンパク質（ｒａｐ）変異体を含む組成物およびその使用
CA2969926C (en) 2009-02-20 2018-05-15 2-Bbb Medicines B.V. Glutathione-based drug delivery system
IL295075A (en) 2009-05-06 2022-09-01 Laboratory Skin Care Inc Preparations for administration through the skin that include complexes of an active substance with calcium phosphate and methods of using them
WO2017112902A1 (en) 2015-12-23 2017-06-29 Oric Pharmaceuticals, Inc. Inhibitors of glucocorticoid receptor
US11110103B2 (en) 2015-12-23 2021-09-07 Oric Pharmaceuticals, Inc. Inhibitors of glucocorticoid receptor
CN108713023B (zh) 2015-12-23 2021-10-26 欧瑞克制药公司 糖皮质激素受体抑制剂
DK3523315T3 (da) 2016-10-07 2021-05-03 Oric Pharmaceuticals Inc Inhibitor af glucocorticoidreceptor

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5232917A (en) * 1987-08-25 1993-08-03 University Of Southern California Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series

Also Published As

Publication number Publication date
AU687088B2 (en) 1998-02-19
ATE171873T1 (de) 1998-10-15
WO1995004536A1 (en) 1995-02-16
AU7496894A (en) 1995-02-28
CA2166332C (en) 2005-05-10
NZ271363A (en) 1999-06-29
JP3828926B2 (ja) 2006-10-04
DE69413829T2 (de) 1999-04-15
US5741787A (en) 1998-04-21
JPH09501172A (ja) 1997-02-04
ES2124905T3 (es) 1999-02-16
CA2166332A1 (en) 1995-02-16
EP0712311B1 (en) 1998-10-07
EP0712311A1 (en) 1996-05-22
DE69413829D1 (de) 1998-11-12

Similar Documents

Publication Publication Date Title
DK0712311T3 (da) Antiglucocorticoidsteroider til behandling af angstlidelser
DK0683780T3 (da) Imidazopyridiner og deres anvendelse til behandling af mave-tarm-sygdomme
ATE252560T1 (de) Steroidrezeptor-modulator verbindungen und methoden
SE9604793D0 (sv) New polymorphs
BG104315A (en) Prostaglandine agonists and their application for the treatment of osteal diseases
DE60229530D1 (de) Substituierte piperazine als modulatoren des melanocortinrezeptors
NO965516D0 (no) Sterolderivater anvendt til regulering av meiose
ATE255589T1 (de) Kristallin form i von clarithromycin
ES2126122T3 (es) Nitrato-aminoacido-disulfuros para la terapia de enfermedades del sistema cardio-circulatorio.
DK1063995T3 (da) Kombination til behandling af alkoholafhængighed indeholdende en opiod-antagonist og en NMDA-receptorkompleks-modulator
DK0800536T3 (da) Rekombinante IL-5 antagonister, der er nyttige til behandling af IL-5-medierede lidelser
BR9913072A (pt) Sistemas de anel azacìclico, composição farmacêutica, e, processo para induzir a analgesia
BG102250A (en) The use of marigold-extracted glycosides for the treatment of psoriasis
DK0989973T3 (da) Chalconer med antiproliferativ aktivitet
DE69838882D1 (de) Pharmazeutisch wirksame verbindungen und methoden zu ihrer anwendung
DK0748314T3 (da) Tetrasubstituerede imidazolderivater, fremgangsmåde til deres fremstilling, deres anvendelse som lægemidler og farmaceutiske præparater med indhold deraf
DK0996435T3 (da) Aminosyrederivater anvendelige til behandling af slagtilfælde
DE60209248D1 (de) Verwendung von (11beta, 17beta)-11-(1,3-benzodioxol-5-yl)-17-hydroxy-17-(1-propinyl)-estra-4,9-dien-3-on zur behandlung von schweren depressionen
DK1322660T3 (da) 17a-fluoralkylsteroider, fremgangsmåde til deres fremstilling og farmaceutiske sammensætninger, der indeholder disse forbindelser
DK0675895T3 (da) Etoposidderivater, fremgangsmåde til fremstilling deraf, anvendelse deraf som lægemiddel og anvendelse deraf til fremstilling af et lægemiddel til anticancerbehandling
SE9301831D0 (sv) Pharmaceutical compositions
AU2796695A (en) Pyrrolidine derivatives for the treatment of cholecystokinine and gastrine-related disorders
MXPA01009174A (es) Antagonistas de endotelina novedosos derivados de piridazina.
DK1235850T3 (da) Umættede 14,15-cyclopropano-androstaner, fremgangsmåde til deres fremstilling og farmaceutiske præparater indeholdende disse forbindelser